Tuesday 30 March 2021, 6.30pm –8.00pm
Is there a case to be made for the use of GLP-1 receptor agonists (RAs) as second line therapy in patients who have failed to achieve HbA1c control with Metformin?
In this online masterclass, a panel of diabetes experts will tackle this question, including discussions of glycaemic control, renal considerations, the barriers to using GLP-1 RAs second line, a case study example, and a panel discussion of how to practically implement best practice guidelines in a primary care setting.
This masterclass will be hosted by:
Prof Merlin Thomas - Director of the Biochemistry of Diabetes Complications Laboratory, Department of Diabetes, Monash University, VIC
Dr Ted Wu - Director of the Diabetes Centre, The Royal Prince Alfred Hospital, NSW
A/Prof Ralph Audehm - General Practitioner, Carlton Family Medical Practice and Honorary Clinical Associate Professor, Department of General Practice, The University of Melbourne, VIC